Analyze Diet
The Journal of antimicrobial chemotherapy2011; 66(10); 2248-2254; doi: 10.1093/jac/dkr289

Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data.

Abstract: We investigated whether Acinetobacter baumannii isolates of veterinary origin shared common molecular characteristics with those described in humans. Methods: Nineteen A. baumannii isolates collected in pets and horses were analysed. Clonality was studied using repetitive extragenic palindromic PCR (rep-PCR) and multilocus sequence typing (MLST). PCR and DNA sequencing for various β-lactamase, aminoglycoside-modifying enzyme, gyrA and parC, ISAba1 and IS1133, adeR and adeS of the AdeABC efflux pump, carO porin and class 1/2/3 integron genes were performed. Results: Two main clones [A (n = 8) and B (n = 9)] were observed by rep-PCR. MLST indicated that clone A contained isolates of sequence type (ST) ST12 (international clone II) and clone B contained isolates of ST15 (international clone I). Two isolates of ST10 and ST20 were also noted. Seventeen isolates were resistant to gentamicin, 12 to ciprofloxacin and 3 to carbapenems. Isolates of ST12 carried bla(OXA-66), bla(ADC-25), bla(TEM-1), aacC2 and IS1133. Strains of ST15 possessed bla(OXA-69), bla(ADC-11), bla(TEM-1) and a class 1 integron carrying aacC1 and aadA1. ISAba1 was found upstream of bla(ADC) (one ST10 and one ST12) and/or bla(OXA-66) (seven ST12). Twelve isolates of different STs contained the substitutions Ser83Leu in GyrA and Ser80Leu or Glu84Lys in ParC. Significant disruptions of CarO porin and overexpressed efflux pumps were not observed. The majority of infections were hospital acquired and in animals with predisposing conditions for infection. Conclusions: STs and the molecular background of resistance observed in our collection have been frequently described in A. baumannii detected in human patients. Animals should be considered as a potential reservoir of multidrug-resistant A. baumannii.
Publication Date: 2011-07-06 PubMed ID: 21733964PubMed Central: PMC3172040DOI: 10.1093/jac/dkr289Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study focuses on investigating if Acinetobacter baumannii, a bacteria found in pets and horses, shares molecular characteristics with strains found in humans, with the hopes of understanding more about antibiotic resistance and bacterial transmission.

Methods

The researchers used several methods ranging from collection and analysis of A. baumannii isolates to various techniques of DNA sequencing.

  • Nineteen isolates of A. baumannii were collected from pets and horses for examination.
  • Repetitive extragenic palindromic PCR (rep-PCR) and multilocus sequence typing (MLST) methods were utilized for studying clonality of the samples.
  • Various gene sequences were examined using PCR and DNA sequencing, these genes play a role in antibiotic resistance.

Results

The outcomes of the research presented insights about the genetic characteristics and antibiotic resistance patterns of A. baumannii isolates.

  • Two main clones A and B were identified using rep-PCR, clone A containing isolates of sequence type ST12 and clone B containing those of ST15. Some isolates of ST10 and ST20 were also observed.
  • Most isolates displayed resistance to various antibiotics: 17 isolates to gentamicin, 12 to ciprofloxacin, and 3 to carbapenems.
  • Different isolates carried various antibiotic-resistance genes such as blaOXA-66, blaADC-25, blaTEM-1, associated with ST12 and blaOXA-69, blaADC-11, blaTEM-1 related to ST15.
  • Significant disruptions of CarO porin (part of bacterial cell wall) and overexpressed efflux pumps (part of the antibiotic-resistance mechanism) were not seen.
  • Interestingly, a majority of infections were hospital-acquired and seen in animals having predisposing conditions for infection.

Conclusions

The sequence types and molecular features linked to resistance observed in A. baumannii obtained from animals were similar to those found in human patients.

  • This suggests that pets and horses could potentially serve as a reservoir for the multidrug-resistant A. baumannii, indicating a potential risk of antibiotic-resistant bacterial transmission between animals and humans.
  • This enforces the importance of implementing strict antibiotic policies not only in human healthcare settings but also in veterinary medicine to curb the rise and spread of antibiotic resistance.

Cite This Article

APA
Endimiani A, Hujer KM, Hujer AM, Bertschy I, Rossano A, Koch C, Gerber V, Francey T, Bonomo RA, Perreten V. (2011). Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data. J Antimicrob Chemother, 66(10), 2248-2254. https://doi.org/10.1093/jac/dkr289

Publication

ISSN: 1460-2091
NlmUniqueID: 7513617
Country: England
Language: English
Volume: 66
Issue: 10
Pages: 2248-2254

Researcher Affiliations

Endimiani, Andrea
  • Institute of Veterinary Bacteriology, University of Bern, Länggass-Strasse 122, CH-3001 Bern, Switzerland. aendimiani@gmail.com
Hujer, Kristine M
    Hujer, Andrea M
      Bertschy, Isabelle
        Rossano, Alexandra
          Koch, Christoph
            Gerber, Vinzenz
              Francey, Thierry
                Bonomo, Robert A
                  Perreten, Vincent

                    MeSH Terms

                    • Acinetobacter Infections / drug therapy
                    • Acinetobacter Infections / microbiology
                    • Acinetobacter Infections / veterinary
                    • Acinetobacter baumannii / genetics
                    • Acinetobacter baumannii / isolation & purification
                    • Acinetobacter baumannii / pathogenicity
                    • Animals
                    • Anti-Bacterial Agents / pharmacology
                    • Bacterial Typing Techniques
                    • Base Sequence
                    • DNA, Bacterial / genetics
                    • Disease Reservoirs / microbiology
                    • Disease Reservoirs / veterinary
                    • Drug Resistance, Multiple, Bacterial / genetics
                    • Horses / microbiology
                    • Microbial Sensitivity Tests
                    • Multilocus Sequence Typing
                    • Pets / microbiology
                    • Phenotype
                    • Sequence Analysis, DNA
                    • Switzerland

                    Grant Funding

                    • AI063517-07 / NIAID NIH HHS
                    • AI072219-05 / NIAID NIH HHS

                    References

                    This article includes 43 references
                    1. Munoz-Price LS, Weinstein RA. Acinetobacter infection.. N Engl J Med 2008 Mar 20;358(12):1271-81.
                      doi: 10.1056/NEJMra070741pubmed: 18354105google scholar: lookup
                    2. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii.. Antimicrob Agents Chemother 2007 Oct;51(10):3471-84.
                      doi: 10.1128/AAC.01464-06pmc: PMC2043292pubmed: 17646423google scholar: lookup
                    3. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen.. Clin Microbiol Rev 2008 Jul;21(3):538-82.
                      doi: 10.1128/CMR.00058-07pmc: PMC2493088pubmed: 18625687google scholar: lookup
                    4. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D beta-lactamases.. Antimicrob Agents Chemother 2010 Jan;54(1):24-38.
                      doi: 10.1128/AAC.01512-08pmc: PMC2798486pubmed: 19721065google scholar: lookup
                    5. Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, Ecker DJ, Adams MD, Toltzis P, Dul MJ, Windau A, Bajaksouzian S, Jacobs MR, Salata RA, Bonomo RA. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.. J Antimicrob Chemother 2010 Aug;65(8):1807-18.
                      doi: 10.1093/jac/dkq191pmc: PMC2904665pubmed: 20513702google scholar: lookup
                    6. Rodríguez-Baño J, García L, Ramírez E, Martínez-Martínez L, Muniain MA, Fernández-Cuenca F, Beltrán M, Gálvez J, Rodríguez JM, Velasco C, Morillo C, Perez F, Endimiani A, Bonomo RA, Pascual A. Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.. Am J Infect Control 2009 Nov;37(9):715-22.
                      doi: 10.1016/j.ajic.2009.01.008pmc: PMC2783564pubmed: 19457584google scholar: lookup
                    7. Perez F, Hujer AM, Hulten EA, Fishbain J, Hujer KM, Aron D, Thweatt K, Donskey CJ, Bonomo RA. Antibiotic resistance determinants in Acinetobacter spp and clinical outcomes in patients from a major military treatment facility.. Am J Infect Control 2010 Feb;38(1):63-5.
                      doi: 10.1016/j.ajic.2009.05.007pmc: PMC4085753pubmed: 19783325google scholar: lookup
                    8. van Dessel H, Dijkshoorn L, van der Reijden T, Bakker N, Paauw A, van den Broek P, Verhoef J, Brisse S. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals.. Res Microbiol 2004 Mar;155(2):105-12.
                      doi: 10.1016/j.resmic.2003.10.003pubmed: 14990262google scholar: lookup
                    9. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii.. Clin Microbiol Infect 2007 Aug;13(8):807-15.
                    10. Dijkshoorn L, Aucken H, Gerner-Smidt P, Janssen P, Kaufmann ME, Garaizar J, Ursing J, Pitt TL. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods.. J Clin Microbiol 1996 Jun;34(6):1519-25.
                    11. Ecker JA, Massire C, Hall TA, Ranken R, Pennella TT, Agasino Ivy C, Blyn LB, Hofstadler SA, Endy TP, Scott PT, Lindler L, Hamilton T, Gaddy C, Snow K, Pe M, Fishbain J, Craft D, Deye G, Riddell S, Milstrey E, Petruccelli B, Brisse S, Harpin V, Schink A, Ecker DJ, Sampath R, Eshoo MW. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry.. J Clin Microbiol 2006 Aug;44(8):2921-32.
                      doi: 10.1128/JCM.00619-06pmc: PMC1594644pubmed: 16891513google scholar: lookup
                    12. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool.. PLoS One 2010 Apr 7;5(4):e10034.
                    13. Vaneechoutte M, Devriese LA, Dijkshoorn L, Lamote B, Deprez P, Verschraegen G, Haesebrouck F. Acinetobacter baumannii-infected vascular catheters collected from horses in an equine clinic.. J Clin Microbiol 2000 Nov;38(11):4280-1.
                    14. Francey T, Gaschen F, Nicolet J, Burnens AP. The role of Acinetobacter baumannii as a nosocomial pathogen for dogs and cats in an intensive care unit.. J Vet Intern Med 2000 Mar-Apr;14(2):177-83.
                    15. Boerlin P, Eugster S, Gaschen F, Straub R, Schawalder P. Transmission of opportunistic pathogens in a veterinary teaching hospital.. Vet Microbiol 2001 Oct 1;82(4):347-59.
                      doi: 10.1016/S0378-1135(01)00396-0pubmed: 11506928google scholar: lookup
                    16. Brachelente C, Wiener D, Malik Y, Huessy D. A case of necrotizing fasciitis with septic shock in a cat caused by Acinetobacter baumannii.. Vet Dermatol 2007 Dec;18(6):432-8.
                    17. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 1.3. 2011.
                    18. Vila J, Marcos MA, Jimenez de Anta MT. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex.. J Med Microbiol 1996 Jun;44(6):482-9.
                      doi: 10.1099/00222615-44-6-482pubmed: 8636966google scholar: lookup
                    19. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center.. Antimicrob Agents Chemother 2006 Dec;50(12):4114-23.
                      doi: 10.1128/AAC.00778-06pmc: PMC1694013pubmed: 17000742google scholar: lookup
                    20. Mazel D, Dychinco B, Webb VA, Davies J. Antibiotic resistance in the ECOR collection: integrons and identification of a novel aad gene.. Antimicrob Agents Chemother 2000 Jun;44(6):1568-74.
                    21. Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.. Antimicrob Agents Chemother 2000 Mar;44(3):622-32.
                      doi: 10.1128/AAC.44.3.622-632.2000pmc: PMC89737pubmed: 10681329google scholar: lookup
                    22. Marchand I, Damier-Piolle L, Courvalin P, Lambert T. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system.. Antimicrob Agents Chemother 2004 Sep;48(9):3298-304.
                    23. Bratu S, Landman D, Martin DA, Georgescu C, Quale J. Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.. Antimicrob Agents Chemother 2008 Sep;52(9):2999-3005.
                      doi: 10.1128/AAC.01684-07pmc: PMC2533509pubmed: 18591275google scholar: lookup
                    24. Héritier C, Poirel L, Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii.. Clin Microbiol Infect 2006 Feb;12(2):123-30.
                    25. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.. FEMS Microbiol Lett 2006 May;258(1):72-7.
                    26. Hujer KM, Hujer AM, Endimiani A, Thomson JM, Adams MD, Goglin K, Rather PN, Pennella TT, Massire C, Eshoo MW, Sampath R, Blyn LB, Ecker DJ, Bonomo RA. Rapid determination of quinolone resistance in Acinetobacter spp.. J Clin Microbiol 2009 May;47(5):1436-42.
                      doi: 10.1128/JCM.02380-08pmc: PMC2681857pubmed: 19297590google scholar: lookup
                    27. Paterson DL, Rice LB, Bonomo RA. Rapid method of extraction and analysis of extended-spectrum beta-lactamases from clinical strains of Klebsiella pneumoniae.. Clin Microbiol Infect 2001 Dec;7(12):709-11.
                    28. Endimiani A, Hujer AM, Perez F, Bethel CR, Hujer KM, Kroeger J, Oethinger M, Paterson DL, Adams MD, Jacobs MR, Diekema DJ, Hall GS, Jenkins SG, Rice LB, Tenover FC, Bonomo RA. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.. J Antimicrob Chemother 2009 Mar;63(3):427-37.
                      doi: 10.1093/jac/dkn547pmc: PMC2640158pubmed: 19155227google scholar: lookup
                    29. Wortmann G, Weintrob A, Barber M, Scott P, Zoll ST, Eshoo MW, Sampath R, Ecker DJ, Massire C. Genotypic evolution of Acinetobacter baumannii strains in an outbreak associated with war trauma.. Infect Control Hosp Epidemiol 2008 Jun;29(6):553-5.
                      doi: 10.1086/588221pubmed: 18510464google scholar: lookup
                    30. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii.. J Antimicrob Chemother 2010 Feb;65(2):233-8.
                      doi: 10.1093/jac/dkp428pubmed: 19996144google scholar: lookup
                    31. D'Arezzo S, Capone A, Petrosillo N, Visca P, Ballardini M, Bartolini S, Bordi E, Di Stefano A, Galiè M, Minniti R, Meledandri M, Pacciani L, Parisi G, Prignano G, Santini C, Valmarin M, Venditti M, Ziantoni S. Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy).. Clin Microbiol Infect 2009 Apr;15(4):347-57.
                    32. Kohlenberg A, Brümmer S, Higgins PG, Sohr D, Piening BC, de Grahl C, Halle E, Rüden H, Seifert H. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre.. J Med Microbiol 2009 Nov;58(Pt 11):1499-1507.
                      doi: 10.1099/jmm.0.012302-0pubmed: 19589905google scholar: lookup
                    33. Doi Y, Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides.. Clin Infect Dis 2007 Jul 1;45(1):88-94.
                      doi: 10.1086/518605pubmed: 17554708google scholar: lookup
                    34. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes.. Drug Resist Updat 2010 Dec;13(6):151-71.
                      doi: 10.1016/j.drup.2010.08.003pmc: PMC2992599pubmed: 20833577google scholar: lookup
                    35. Abbott Y, O'Mahony R, Leonard N, Quinn PJ, van der Reijden T, Dijkshoorn L, Fanning S. Characterization of a 2.6 kbp variable region within a class 1 integron found in an Acinetobacter baumannii strain isolated from a horse.. J Antimicrob Chemother 2005 Mar;55(3):367-70.
                      doi: 10.1093/jac/dkh543pubmed: 15681585google scholar: lookup
                    36. Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones.. J Med Microbiol 2004 Dec;53(Pt 12):1233-1240.
                      doi: 10.1099/jmm.0.45716-0pubmed: 15585503google scholar: lookup
                    37. Srinivasan VB, Rajamohan G, Pancholi P, Stevenson K, Tadesse D, Patchanee P, Marcon M, Gebreyes WA. Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA.. Ann Clin Microbiol Antimicrob 2009 Jun 17;8:21.
                      doi: 10.1186/1476-0711-8-21pmc: PMC2705342pubmed: 19531268google scholar: lookup
                    38. Kansakar P, Dorji D, Chongtrakool P, Mingmongkolchai S, Mokmake B, Dubbs P. Local dissemination of multidrug-resistant Acinetobacter baumannii clones in a Thai hospital.. Microb Drug Resist 2011 Mar;17(1):109-19.
                      doi: 10.1089/mdr.2010.0062pubmed: 21117966google scholar: lookup
                    39. Segal H, Thomas R, Gay Elisha B. Characterization of class 1 integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii.. Plasmid 2003 Mar;49(2):169-78.
                      doi: 10.1016/S0147-619X(03)00011-8pubmed: 12726770google scholar: lookup
                    40. Adams-Haduch JM, Paterson DL, Sidjabat HE, Pasculle AW, Potoski BA, Muto CA, Harrison LH, Doi Y. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.. Antimicrob Agents Chemother 2008 Nov;52(11):3837-43.
                      doi: 10.1128/AAC.00570-08pmc: PMC2573138pubmed: 18725452google scholar: lookup
                    41. Hamouda A, Amyes SG. Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin.. J Antimicrob Chemother 2004 Sep;54(3):695-6.
                      doi: 10.1093/jac/dkh368pubmed: 15282231google scholar: lookup
                    42. Vila J, Ruiz J, Goñi P, Jimenez de Anta T. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.. J Antimicrob Chemother 1997 Jun;39(6):757-62.
                      doi: 10.1093/jac/39.6.757pubmed: 9222045google scholar: lookup
                    43. Guardabassi L, Schwarz S, Lloyd DH. Pet animals as reservoirs of antimicrobial-resistant bacteria.. J Antimicrob Chemother 2004 Aug;54(2):321-32.
                      doi: 10.1093/jac/dkh332pubmed: 15254022google scholar: lookup

                    Citations

                    This article has been cited 45 times.